864 related articles for article (PubMed ID: 25848966)
1. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
2. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
Warne T; Moukhametzianov R; Baker JG; Nehmé R; Edwards PC; Leslie AG; Schertler GF; Tate CG
Nature; 2011 Jan; 469(7329):241-4. PubMed ID: 21228877
[TBL] [Abstract][Full Text] [Related]
3. Function-specific virtual screening for GPCR ligands using a combined scoring method.
Kooistra AJ; Vischer HF; McNaught-Flores D; Leurs R; de Esch IJ; de Graaf C
Sci Rep; 2016 Jun; 6():28288. PubMed ID: 27339552
[TBL] [Abstract][Full Text] [Related]
4. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
Reynolds KA; Katritch V; Abagyan R
J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
[TBL] [Abstract][Full Text] [Related]
5. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of β
Mori A; Sekito A; Sakamoto K; Ishii K; Nakahara T
Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):527-533. PubMed ID: 28160015
[TBL] [Abstract][Full Text] [Related]
7. Ligand-binding affinity of alternative conformers of human β
Dilcan G; Doruker P; Akten ED
Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937
[TBL] [Abstract][Full Text] [Related]
8. The Principles of Ligand Specificity on beta-2-adrenergic receptor.
Chan HC; Filipek S; Yuan S
Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221
[TBL] [Abstract][Full Text] [Related]
9. Modeling GPCR active state conformations: the β(2)-adrenergic receptor.
Simpson LM; Wall ID; Blaney FE; Reynolds CA
Proteins; 2011 May; 79(5):1441-57. PubMed ID: 21337626
[TBL] [Abstract][Full Text] [Related]
10. Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor.
Bhattacharya S; Vaidehi N
J Am Chem Soc; 2010 Apr; 132(14):5205-14. PubMed ID: 20235532
[TBL] [Abstract][Full Text] [Related]
11. Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy.
Scharf MM; Bünemann M; Baker JG; Kolb P
Mol Pharmacol; 2019 Dec; 96(6):851-861. PubMed ID: 31624135
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
13. Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor.
de Graaf C; Rognan D
J Med Chem; 2008 Aug; 51(16):4978-85. PubMed ID: 18680279
[TBL] [Abstract][Full Text] [Related]
14. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.
Weiss DR; Ahn S; Sassano MF; Kleist A; Zhu X; Strachan R; Roth BL; Lefkowitz RJ; Shoichet BK
ACS Chem Biol; 2013 May; 8(5):1018-26. PubMed ID: 23485065
[TBL] [Abstract][Full Text] [Related]
15. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.
Chandrasekera PC; Wan TC; Gizewski ET; Auchampach JA; Lasley RD
Cell Signal; 2013 Apr; 25(4):736-42. PubMed ID: 23291003
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the β₂-adrenergic receptor is determined by conformational equilibrium in the transmembrane region.
Kofuku Y; Ueda T; Okude J; Shiraishi Y; Kondo K; Maeda M; Tsujishita H; Shimada I
Nat Commun; 2012; 3():1045. PubMed ID: 22948827
[TBL] [Abstract][Full Text] [Related]
18. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
Tang H; Wang XS; Hsieh JH; Tropsha A
Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
[TBL] [Abstract][Full Text] [Related]
19. Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.
Vilar S; Ferino G; Phatak SS; Berk B; Cavasotto CN; Costanzi S
J Mol Graph Model; 2011 Feb; 29(5):614-23. PubMed ID: 21146435
[TBL] [Abstract][Full Text] [Related]
20. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]